saikosaponin d has been researched along with Inflammation in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 6 (46.15) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, L; Fang, X; Lu, F; Song, X; Sun, J; Wu, X; Zhang, W; Zhao, K | 1 |
| Lu, G; Song, L; Tao, Y | 1 |
| Jin, L; Yang, B; Zhao, L | 1 |
| Gao, ZH; Li, RF; Li, SQ; Li, YY; Liu, WY; Wang, HW; Wang, JG; You, M | 1 |
| Chai, OH; Lee, EJ; Piao, CH; Song, CH | 1 |
| Duan, Q; Kang, T; Liu, M; Naqvi, S; Wang, Z; Xiao, S; Zhang, F; Zhang, G; Zheng, Y | 1 |
| Chen, G; Fu, Y; Yao, L; Yao, T; Zhang, L; Zhou, C | 1 |
| Im, HT; Lee, KT; Shin, JS | 1 |
| Jeon, SY; Kim, MR; Kim, SO; Park, JY; Yang, CH | 1 |
| Kang, MS; Kang, S; Kim, J; Oh, MS; Pak, CJ; Pak, YK; Park, WH; Piao, Y | 1 |
| Cao, Y; Fu, Y; Hu, X; Zhang, N; Zhang, Z | 1 |
| Fu, Y; Liu, W; Shi, M; Wang, J; Wei, Z; Yang, Z | 1 |
| Chang, CC; Chao, JC; Tam, KW; Tsai, YH; Wu, SJ | 1 |
13 other study(ies) available for saikosaponin d and Inflammation
| Article | Year |
|---|---|
Inhibition of Lipopolysaccharide-Induced Inflammatory Bone Loss by Saikosaponin D is Associated with Regulation of the RANKL/RANK Pathway.
Topics: Animals; Anti-Inflammatory Agents; Bone Resorption; Cell Differentiation; Cells, Cultured; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Oleanolic Acid; Osteoclasts; Osteogenesis; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Saponins | 2021 |
Saikosaponin D attenuates inflammatory response and cell apoptosis of lipopolysaccharide-induced lung epithelial cells.
Topics: Acute Lung Injury; Animals; Apoptosis; Epithelial Cells; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; Saponins; Sepsis | 2023 |
Saikosaponin A alleviates Staphylococcus aureus-induced mastitis in mice by inhibiting ferroptosis via SIRT1/Nrf2 pathway.
Topics: Animals; Female; Ferroptosis; Humans; Inflammation; Mastitis; Mice; NF-E2-Related Factor 2; NF-kappa B; Sirtuin 1; Staphylococcus aureus | 2023 |
[Effects of saikosaponin b_2 on inflammation and energy metabolism in mice with acute liver injury induced by LPS/GalN].
Topics: Animals; Chemical and Drug Induced Liver Injury; Cytokines; Energy Metabolism; Galactosamine; Inflammation; Lipopolysaccharides; Liver; Mice; NF-kappa B; Oleanolic Acid; Random Allocation; Saponins; Sirtuins | 2019 |
Saikosaponin A ameliorates nasal inflammation by suppressing IL-6/ROR-γt/STAT3/IL-17/NF-κB pathway in OVA-induced allergic rhinitis.
Topics: Animals; Cytokines; Disease Models, Animal; Immunoglobulin E; Immunoglobulin G; Inflammation; Interleukin-17; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Nasal Mucosa; NF-kappa B; Nuclear Receptor Subfamily 1, Group F, Member 3; Oleanolic Acid; Ovalbumin; Rhinitis, Allergic; Saponins; Signal Transduction; STAT3 Transcription Factor; Th17 Cells; Th2 Cells | 2020 |
Cytotoxicity of Saikosaponin A targets HEKa cell through apoptosis induction by ROS accumulation and inflammation suppression via NF-κB pathway.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Humans; Imiquimod; Immunosuppression Therapy; Inflammation; Keratinocytes; Mice; NF-kappa B; Oleanolic Acid; Reactive Oxygen Species; Saponins; Signal Transduction | 2020 |
Saikosaponin-d Alleviates Renal Inflammation and Cell Apoptosis in a Mouse Model of Sepsis via TCF7/FOSL1/Matrix Metalloproteinase 9 Inhibition.
Topics: Acute Kidney Injury; Animals; Apoptosis; Cell Line; Disease Models, Animal; Epithelial Cells; Hepatocyte Nuclear Factor 1-alpha; Humans; Inflammation; Kidney; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nephritis; Oleanolic Acid; Proto-Oncogene Proteins c-fos; Saponins; Sepsis | 2021 |
Saikosaponin B2 Suppresses Inflammatory Responses Through IKK/IκBα/NF-κB Signaling Inactivation in LPS-Induced RAW 264.7 Macrophages.
Topics: Animals; Anti-Inflammatory Agents; I-kappa B Proteins; Inflammation; Lipopolysaccharides; Macrophages; Mice; NF-kappa B; Oleanolic Acid; RAW 264.7 Cells; Saponins; Signal Transduction | 2019 |
Saikosaponin a, an active compound of Radix Bupleuri, attenuates inflammation in hypertrophied 3T3-L1 adipocytes via ERK/NF-κB signaling pathways.
Topics: 3T3-L1 Cells; Animals; Anti-Inflammatory Agents; Cytokines; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation; Inflammation; Inflammation Mediators; Mice; NF-kappa B; Nitric Oxide; Oleanolic Acid; Saponins; Signal Transduction | 2015 |
Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB.
Topics: Animals; Anti-Inflammatory Agents; Bupleurum; Cell Survival; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Ethanol; Inflammation; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Oleanolic Acid; Plant Roots; Saponins | 2015 |
Saikosaponin a inhibits lipopolysaccharide-oxidative stress and inflammation in Human umbilical vein endothelial cells via preventing TLR4 translocation into lipid rafts.
Topics: Anti-Inflammatory Agents; Blotting, Western; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipopolysaccharides; Membrane Microdomains; Oleanolic Acid; Oxidative Stress; Protein Transport; Reactive Oxygen Species; RNA, Small Interfering; Saponins; Signal Transduction; Toll-Like Receptor 4; Transfection | 2015 |
Saikosaponin a inhibits LPS-induced inflammatory response by inducing liver X receptor alpha activation in primary mouse macrophages.
Topics: Animals; Anti-Inflammatory Agents; ATP Binding Cassette Transporter 1; Cell Membrane; Cell Survival; Cholesterol; Cytokines; Endotoxemia; Female; Inflammation; Lipopolysaccharide Receptors; Lipopolysaccharides; Liver X Receptors; Macrophages; Male; Membrane Microdomains; Mice; Mice, Inbred BALB C; NF-kappa B; Oleanolic Acid; Saponins; Signal Transduction; Toll-Like Receptor 4; Treatment Outcome | 2016 |
Curcumin and saikosaponin a inhibit chemical-induced liver inflammation and fibrosis in rats.
Topics: Animals; Anti-Inflammatory Agents; Bupleurum; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Collagen; Curcuma; Curcumin; Cytokines; Dietary Supplements; Drug Therapy, Combination; Fibrosis; Hydroxyproline; Inflammation; Liver; Male; NF-kappa B; Oleanolic Acid; Phytotherapy; Plant Extracts; Plant Roots; Random Allocation; Rats; Rats, Sprague-Dawley; Rhizome; Saponins; Transforming Growth Factor beta1 | 2010 |